Transient Elastography Market Report 2026

Transient Elastography Market Overview

• Transient Elastography market size has reached to $1.44 billion in 2025 • Expected to grow to $2.65 billion in 2030 at a compound annual growth rate (CAGR) of 13% • Growth Driver: Surge In Chronic Liver Disease Driving The Growth Of The Market Due To Rising Alcohol Consumption And Need For Early Diagnosis • Market Trend: Mindray Introduces Visual Transient Elastography Technology To advance Non-Invasive Liver Disease Diagnosis • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Transient Elastography Market?

Transient elastography is a non-invasive medical device that measures the stiffness of the liver using painless ultrasound-based technology. It is a tool commonly used by doctors to assess liver health and detect conditions like fibrosis and cirrhosis early. The device provides quick and reliable results without the need for a biopsy. It helps improve patient care by allowing regular monitoring of liver disease progression. The main product of transient elastography are standalone devices and portable devices. The transient elastography standalone devices are non-invasive medical instruments used to assess liver stiffness and fat content by sending a painless mechanical vibration into the liver and measuring the speed of the resulting shear wave. The various application involved are liver disease assessment, hepatitis, fibrosis, cirrhosis, other applications used by hospitals, diagnostic centers, research institutes and other end users

What Is The Transient Elastography Market Growth Forecast?

The transient elastography market size is expected to see rapid growth in the next few years. It will grow to $2.65 billion in 2030 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to increasing demand for point-of-care diagnostic devices, rising investments in early disease detection, expansion of screening programs for hepatitis and fibrosis, growing adoption of portable diagnostic tools, increasing integration of ai-assisted image analysis. Major trends in the forecast period include increasing adoption of non-invasive liver diagnostics, rising demand for portable elastography devices, growing integration of elastography with ultrasound platforms, expansion of routine liver disease screening, enhanced focus on early fibrosis detection.

What Is The Driver Of The Transient Elastography Market?

The rising prevalence of chronic liver diseases is expected to propel the growth of the transient elastography market going forward. Chronic liver disease refers to a long-term, progressive condition in which the liver becomes damaged and its function gradually declines due to ongoing inflammation or scarring. Factors that increase chronic liver disease include excessive alcohol consumption, which is a major contributor to liver fibrosis and cirrhosis and increases the need for regular liver health assessment. This growing burden of alcohol-related liver damage, alongside other chronic liver conditions, is fueling demand for transient elastography as a non-invasive tool to measure liver stiffness and detect early signs of deterioration. For instance, in April 2024, according to GOV.UK, a UK-based government agency, hospital admission rates due to liver disease continue to rise. In the financial year ending 2023, admissions increased to 155.2 (152.9 to 157.5) per 100,000 population, up from 150.6 (148.2 to 152.9) the previous year. Therefore, the rising prevalence of chronic liver diseases is driving the growth of the transient elastography industry.

Key Players In The Global Transient Elastography Market

Major companies operating in the transient elastography market are Siemens Healthcare GmbH, GE HealthCare Technologies Inc., Mindray Bio‑Medical Electronics Co. Ltd., Tawazun Health Ltd., Echosens SA., CHISON Medical Technologies Co. Ltd., Neusoft Medical Systems Co. Ltd., Hisky Medical, Wuxi Hisky Medical Technologies Co. Ltd., Nexgen Therapeutics, Liver Scan Group Limited, Eieling Technology Limited, SMEDA Medical Co. Ltd., Sandhill Scientific Inc.

Global Transient Elastography Market Trends and Insights

Major companies operating in the transient elastography market are developing innovative products such as visual transient elastography to provide real-time visualization of liver tissue stiffness, enhance diagnostic accuracy, and support earlier detection and monitoring of liver diseases through non-invasive imaging. Visual transient elastography refers to a non-invasive imaging technique that integrates ultrasound with elastography to visually measure and map liver tissue stiffness in real time. For instance, in June 2023, Mindray, a China-based developer and manufacturer of medical device solutions, launched the Hepatus 6 Diagnostic Ultrasound System. The Hepatus 6 combines transient elastography with real-time 2D diagnostic ultrasound in a single platform, making it well-suited for non-invasive liver disease assessment. Its “Visual Transient Elastography (ViTE)” technology quantifies liver fibrosis and steatosis while providing simultaneous ultrasound imaging. Designed specifically for liver evaluation, the system integrates elastography directly into a diagnostic ultrasound platform to streamline liver disease detection, diagnosis, and monitoring.

What Are Latest Mergers And Acquisitions In The Transient Elastography Market?

In June 2025, Tawazun Health, a UK-based provider of community and holistic healthcare services, partnered with LiverScan Group for an undisclosed amount. With this collaboration, Tawazun Health aims to expand access to high-quality FibroScan transient elastography services across the U.K., improving early detection and management of liver diseases through enhanced service reach and clinical integration. LiverScan Group is an UK-based company focused on liver health assessment and disease identification using transient elastography technology.

What Defines the Transient Elastography Market?

The transient elastography market consists of sales of fibroscan, hepatus 6 diagnostic ultrasound system, aixplorer ultimate, resona 7 ultrasound system, and logiq e10 series. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Transient Elastography Market Report 2026?

The transient elastography market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the transient elastography industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.